Objective: It has been shown that Ang-(1-7) has cardioprotective actions. To directly investigate the effects of Ang-(1-7) specifically in the heart, we generated and characterized transgenic (TG) rats which express an Ang-(1-7)-producing fusion protein driven by the α-MHC promoter.
Methods and Results: After microinjection of the transgene into fertilized rat zygotes, we obtained four different transgenic lines. Homozygous animals were analyzed with regard to the expression profile of the transgene by ribonuclease protection assay. Transgene expression was detected mainly in the heart with weak or no expression in other organs. Heterozygous TG(hA-1-7)L7301 rats presented a significant increase in cardiac Ang-(1-7) concentration compared with control rats (17.1±2.1 versus 3.9±1.4 pg/mg protein in SD rats). Radiotelemetry analysis revealed that TG rats presented no significant changes in blood pressure and heart rate compared with normal rats. Overexpression of Ang-(1-7) in the heart produced slight improvement in resting cardiac function (+ dT/dt: 81530±1305.0 versus 77470±345.5 g/s bpm in SD rats, p < 0.05), which was in keeping with the enhanced [Ca2+] handling observed in cardiomyocytes of TG rats. TG(hA-1-7)L7301 rats also showed a greater capacity to withstand stress since TG rats showed a less pronounced deposition of collagen type III and fibronectin induced by isoproterenol treatment in the subendocardial area than in corresponding controls. In addition, hearts from TG rats showed reduced incidence and duration of reperfusion arrhythmias in comparison with SD rats.
Conclusion: These results indicate that Ang-(1-7) has blood pressure-independent, antifibrotic effects, acting directly in the heart.
Bader, M. ( 2002) Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on transgenic animal models. J Mol Cell Cardiol34: 1455-1462.
2.
Benter, I.F., Yousif, M.H., Anim, J.T., Cojocel, C. and Diz, D.I. ( 2006) Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-name . Am J Physiol Heart Circ Physiol290: H684-691.
3.
Botelho, L.M., Block, C.H., Khosla, M.C. and Santos, R.A. ( 1994) Plasma angiotensin(1-7) immunoreactivity is increased by salt load, water deprivation, and hemorrhage. Peptides15: 723-729.
4.
Bradford, M.M. ( 1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem72: 248-254.
5.
Castro, C.H., Santos, R.A., Ferreira, A.J., Bader, M., Alenina, N. and Almeida, A.P. ( 2005) Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with At1 and At2 receptors in the mouse heart. Hypertension46: 937-942.
6.
De Mello, W.C. ( 2004) Angiotensin (1-7) Reestablishes impulse conduction in cardiac muscle during ischaemia-reperfusion. The role of the sodium pump. J Renin Angiotensin Aldosterone Syst5: 203-208.
7.
De Mello, W.C., Ferrario, C.M. and Jessup, J.A. ( 2007) Beneficial versus harmful effects of angiotensin (1-7) on impulse propagation and cardiac arrhythmias in the failing heart. J Renin Angiotensin Aldosterone Syst8: 74-80.
8.
Dias-Peixoto, M.F., Santos, R.A., Gomes, E.R., Alves, M.N., Almeida, P.W., Greco, L. et al. (2008) Molecular mechanisms involved in the angiotensin-(1-7)/Mas signaling pathway in cardiomyocytes. Hypertension52: 542-548.
9.
Diez-Freire, C., Vazquez, J., Correa De Adjounian, M.F., Ferrari, M.F., Yuan, L., Silver, X. et al. (2006) ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. Physiol Genomics27: 12-19.
10.
Ferrario, C.M. and Chappell, M.C. ( 2004) Novel angiotensin peptides. Cell Mol Life Sci61: 2720-2727.
11.
Ferreira, A.J., Oliveira, T.L., Castro, M.C., Almeida, A.P., Castro, C.H., Caliari, M.V. et al. (2007) Isoproterenol-induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin-(1-7) analogue AVE 0991. Life Sci81: 916-923.
12.
Ferreira, A.J., Santos, R.A. and Almeida, A.P. ( 2001) Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion. Hypertension38: 665-668.
13.
Ferreira, A.J., Santos, R.A. and Almeida, A.P. ( 2002) Angiotensin-(1-7) improves the post-ischemic function in isolated perfused rat hearts. Braz J Med Biol Res35: 1083-1090.
14.
Grobe, J.L., Mecca, A.P., Lingis, M., Shenoy, V., Bolton, T.A., Machado, J.M. et al. (2007) Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol292: H736-742.
15.
Grobe, J.L., Mecca, A.P., Mao, H. and Katovich, M.J. ( 2006) Chronic angiotensin-(1-7) prevents cardiac fibrosis in Doca-Salt model of hypertension. Am J Physiol Heart Circ Physiol290: H2417-2423.
16.
Guatimosim, S., Sobie, E.A., Dos Santos Cruz, J., Martin, L.A. and Lederer, W.J. ( 2001) Molecular identification of a TTX-sensitive Ca(2+) current . Am J Physiol Cell Physiol280: C1327-1339.
17.
Hein, L., Stevens, M.E., Barsh, G.S., Pratt, R.E., Kobilka, B.K. and Dzau, V.J. ( 1997) Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci U S A94: 6391-6396.
18.
Lauton-Santos, S., Guatimosim, S., Castro, C.H., Oliveira, F.A., Almeida, A.P., Dias-Peixoto, M.F. et al. (2007) Kinin B1 receptor participates in the control of cardiac function in mice. Life Sci81: 814-822.
19.
Lochard, N., Silversides, D.W., Van Kats, J.P., Mercure, C. and Reudelhuber, T.L. ( 2003) Brain-specific restoration of angiotensin II corrects renal defects seen in angiotensinogen-deficient mice. J Biol Chem278: 2184-2189.
20.
Loot, A.E., Roks, A.J., Henning, R.H., Tio, R.A., Suurmeijer, A.J., Boomsma, F. et al. (2002) Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation105: 1548-1550.
21.
Mahmood, A., Jackman, H.L., Teplitz, L. and Igic, R. ( 2002) Metabolism of angiotensin I in the coronary circulation of normal and diabetic rats. Peptides23: 1171-1175.
22.
Mercure, C., Yogi, A., Callera, G.E., Aranha, A.B., Bader, M., Ferreira, A.J. et al. (2008) Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res103: 1319-1326.
23.
Methot, D., Lapointe, M.C., Touyz, R.M., Yang, X.P., Carretero, O.A., Deschepper, C.F. et al. (1997) Tissue targeting of angiotensin peptides. J Biol Chem272: 12994-12999.
24.
Methot, D., Vankats, J.P., Lochard, N., Tremblay, F., Silversides, D.W. and Reudelhuber, T.L. ( 2001) Development and application of a biological peptide pump for the study of the in vivo actions of angiotensin peptides. Am J Hypertens14: 38S-43S.
25.
Neves, L.A., Almeida, A.P., Khosla, M.C. and Santos, R.A. ( 1995) Metabolism of angiotensin I in isolated rat hearts. effect of angiotensin converting enzyme inhibitors. Biochem Pharmacol50: 1451-1459.
26.
Pan, C.H., Wen, C.H. and Lin, C.S. ( 2008) Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes. Exp Physiol93: 599-612.
27.
Paradis, P., Dali-Youcef, N., Paradis, F.W., Thibault, G. and Nemer, M. ( 2000) Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci U S A97: 931-936.
28.
Popova, E., Krivokharchenko, A., Ganten, D. and Bader, M. ( 2002) Comparison between PMSG- and FSH-induced superovulation for the generation of transgenic rats. Mol Reprod Dev63: 177-182.
29.
Santos, R.A., Brum, J.M., Brosnihan, K.B. and Ferrario, C.M. ( 1990) The renin-angiotensin system during acute myocardial ischemia in dogs. Hypertension15: 1121-127.
30.
Santos, R.A., Castro, C.H., Gava, E., Pinheiro, S.V., Almeida, A.P., Paula, R.D. et al. (2006) Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor Mas knockout mice. Hypertension47: 996-1002.
31.
Santos, R.A., Ferreira, A.J., Nadu, A.P., Braga, A.N., De Almeida, A.P., Campagnole-Santos, M.J. et al. (2004) Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats. Physiol Genomics17: 292-299.
32.
Santos, R.A., Ferreira, A.J., Pinheiro, S.V., Sampaio, W.O., Touyz, R. and Campagnole-Santos, M.J. ( 2005) Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs. Expert Opin Investig Drugs14: 1019-1031.
33.
Van Kats, J.P., Methot, D., Paradis, P., Silversides, D.W. and Reudelhuber, T.L. ( 2001) Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice. Direct and indirect effects of angiotensin II on the heart. J Biol Chem276: 44012-44017.
